Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Goitre and thyroid nodules

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Stridor, rapidly worsening dyspnoea, inability to lie flat, acute neck expansion, facial congestion with airway compromise or severe dysphagia needs emergency ENT, anaesthetic and imaging assessment. A rapidly enlarging hard mass, vocal-cord palsy or suspicious cervical nodes requires urgent cancer-pathway referral even when thyroid function is normal.

Synopsis

Assess diffuse enlargement and focal nodules systematically, separate airway and cancer risk from thyroid function, and route ultrasound, scintigraphy and cytology through current UK pathways.

  • Goitre means thyroid enlargement and can be diffuse or nodular, euthyroid, hypothyroid or hyperthyroid; structure and function must be assessed separately.
  • Most thyroid nodules are benign, but history, examination and structured ultrasound determine which need cytology or specialist surveillance.
  • Ask about growth rate, pain, dysphagia, dyspnoea, positional symptoms, voice change, radiation exposure, family syndromes and previous thyroid disease.
  • Examine size, consistency, mobility, retrosternal signs, tracheal position, cervical nodes and voice; stridor or Pemberton-type congestion requires urgent escalation.
  • Measure TSH before or alongside ultrasound because a suppressed result directs functional scintigraphy and changes whether a nodule should be aspirated.
  • Ultrasound should report both lobes, nodule size and features, cervical nodes and a recognised local risk category, not simply describe a nodule as present.
  • Fine-needle aspiration is the first pathological test for an indicated nodule; size thresholds depend on ultrasound risk, clinical context and current local multidisciplinary guidance.
  • A scintigraphically hot autonomous nodule is rarely malignant and generally does not need routine FNA unless a separate suspicious feature exists.
  • CT of neck and chest helps define retrosternal extension or tracheal compression, but iodinated contrast requires thought when hyperthyroidism or radioiodine treatment is relevant.
  • Normal TSH does not rule out thyroid cancer, and abnormal TSH does not prove a nodule is malignant; avoid collapsing two different questions into one.

Key red flags

Cancer concern

Rapid or progressive growth, hard fixation, suspicious cervical nodes, persistent unexplained hoarseness, prior neck irradiation or a relevant familial syndrome should accelerate specialist and cancer-pathway assessment.

Airway or mediastinal compression

Stridor, orthopnoea, positional dyspnoea, dysphagia, facial plethora or venous distension on arm elevation suggests tracheal, oesophageal or thoracic inlet compromise and may require emergency care.

Acute painful expansion

Sudden pain and enlargement may represent haemorrhage into a cyst or nodule, while fever and focal inflammatory signs raise abscess; airway effect determines urgency.

Investigation priorities

01
TSH with reflex free thyroid hormonesFirst step

Determine whether the structural lesion is euthyroid, hypoactive or autonomous.

Management branches

Airway firstManage compressive neck disease

Stridor, rapid expansion, positional respiratory compromise or venous congestion is present.

  1. Keep the patient in the safest tolerated position, assess ABCDE and summon senior anaesthesia and ENT before airway deterioration makes intervention more difficult.
  2. Use urgent cross-sectional imaging only when the airway is sufficiently stable, with endoscopic assessment and critical-care monitoring directed by the specialist team.
  3. Plan definitive decompression, drainage or thyroid surgery according to cause; do not send a threatened airway through a routine outpatient ultrasound route.

Key medicines

Levothyroxine after definitive hypothyroid treatmentUse an individual once-daily replacement regimen after total thyroidectomy or ablative treatment, selected by age, weight, pregnancy and cardiac risk and titrated against the appropriate TSH target.Do not prescribe TSH-suppressive doses for an ordinary benign nodule. Cancer-specific suppression targets belong to specialist oncology follow-up and require rhythm and bone-risk review.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • British Thyroid Association professional guidanceCurrent UK thyroid-nodule consensus and linked professional resources.
  • NICE NG230 thyroid cancer recommendationsDiagnostic, cytology, multidisciplinary and treatment pathways for thyroid cancer.
  • NICE NG12 suspected cancer recommendationsUrgent referral features and cancer recognition pathway.
  • NICE NG145 structural thyroid recommendationsUse of ultrasound, scintigraphy and functional assessment in thyroid disease.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom